| Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial M Valgimigli, G Campo, M Monti, P Vranckx, G Percoco, C Tumscitz, ... Circulation 125 (16), 2015-2026, 2012 | 824 | 2012 |
| Complications after systematic, random, and image-guided prostate biopsy M Borghesi, H Ahmed, R Nam, E Schaeffer, R Schiavina, S Taneja, ... European urology 71 (3), 353-365, 2017 | 516 | 2017 |
| Two-year outcomes after first-or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre … M Valgimigli, M Tebaldi, M Borghesi, P Vranckx, G Campo, C Tumscitz, ... JACC: Cardiovascular interventions 7 (1), 20-28, 2014 | 161 | 2014 |
| 18F-fluciclovine PET/CT for the detection of prostate cancer relapse: a comparison to 11C-choline PET/CT C Nanni, R Schiavina, E Brunocilla, S Boschi, M Borghesi, L Zanoni, ... Clinical nuclear medicine 40 (8), e386-e391, 2015 | 144 | 2015 |
| Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment … M Valgimigli, M Borghesi, M Tebaldi, P Vranckx, G Parrinello, R Ferrari, ... European Heart Journal 34 (12), 909-919, 2013 | 135 | 2013 |
| Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and management M Borghesi, E Brunocilla, R Schiavina, G Martorana Clinical genitourinary cancer 11 (1), 5-9, 2013 | 113 | 2013 |
| PADUA and RENAL nephrometry scores correlate with perioperative outcomes of robot‐assisted partial nephrectomy: analysis of the Vattikuti Global Quality Initiative in Robotic … R Schiavina, G Novara, M Borghesi, V Ficarra, R Ahlawat, DA Moon, ... BJU international 119 (3), 456-463, 2017 | 101 | 2017 |
| Perioperative complications and mortality after radical cystectomy when using a standardized reporting methodology R Schiavina, M Borghesi, M Guidi, V Vagnoni, Z Zukerman, C Pultrone, ... Clinical genitourinary cancer 11 (2), 189-197, 2013 | 92 | 2013 |
| 11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel F Ceci, P Castellucci, T Graziani, R Schiavina, R Renzi, M Borghesi, ... European journal of nuclear medicine and molecular imaging 43, 84-91, 2016 | 90 | 2016 |
| An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer M Ferro, MD Vartolomei, GI Russo, F Cantiello, ARA Farhan, ... World journal of urology 37, 507-514, 2019 | 87 | 2019 |
| MRI displays the prostatic cancer anatomy and improves the bundles management before robot-assisted radical prostatectomy R Schiavina, L Bianchi, M Borghesi, H Dababneh, F Chessa, CV Pultrone, ... Journal of endourology 32 (4), 315-321, 2018 | 84 | 2018 |
| 18F-FACBC compared with 11C-choline PET/CT in patients with biochemical relapse after radical prostatectomy: a prospective study in 28 patients C Nanni, R Schiavina, E Brunocilla, M Borghesi, V Ambrosini, L Zanoni, ... Clinical Genitourinary Cancer 12 (2), 106-110, 2014 | 84 | 2014 |
| Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia Study I. Short-versus long-term duration of dual-antiplatelet therapy after coronary … M Valgimigli, G Campo, M Monti, P Vranckx, G Percoco, C Tumscitz, ... Circulation 125 (16), 2015-2026, 2012 | 81 | 2012 |
| Systemic inflammatory markers and oncologic outcomes in patients with high-risk non–muscle-invasive urothelial bladder cancer F Cantiello, GI Russo, MD Vartolomei, ARA Farhan, D Terracciano, ... European urology oncology 1 (5), 403-410, 2018 | 80 | 2018 |
| The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate‐and high‐risk prostate cancer R Schiavina, F Manferrari, M Garofalo, A Bertaccini, V Vagnoni, M Guidi, ... BJU international 108 (8), 1262-1268, 2011 | 71 | 2011 |
| Can testis-sparing surgery for small testicular masses be considered a valid alternative to radical orchiectomy? A prospective single-center study G Gentile, E Brunocilla, A Franceschelli, R Schiavina, C Pultrone, ... Clinical genitourinary cancer 11 (4), 522-526, 2013 | 70 | 2013 |
| Expanding utilization of robotic partial nephrectomy for clinical T1b and complex T1a renal masses M Borghesi, R Schiavina, M Gan, G Novara, A Mottrie, V Ficarra World journal of urology 31, 499-504, 2013 | 68 | 2013 |
| Validation of neutrophil-to-lymphocyte ratio in a multi-institutional cohort of patients with T1G3 non–muscle-invasive bladder cancer MD Vartolomei, M Ferro, F Cantiello, G Lucarelli, S Di Stasi, R Hurle, ... Clinical Genitourinary Cancer 16 (6), 445-452, 2018 | 66 | 2018 |
| Long‐term evaluation of survival, continence and potency (SCP) outcomes after robot‐assisted radical prostatectomy (RARP) V Ficarra, M Borghesi, N Suardi, G De Naeyer, G Novara, P Schatteman, ... BJU international 112 (3), 338-345, 2013 | 65 | 2013 |
| Prediction nomogram for 68Ga-PSMA-11 PET/CT in different clinical settings of PSA failure after radical treatment for prostate cancer F Ceci, L Bianchi, M Borghesi, G Polverari, A Farolfi, A Briganti, ... European journal of nuclear medicine and molecular imaging 47, 136-146, 2020 | 60 | 2020 |
